Details for 2014752705
Up to date per 02.04.2026
Actions
Details for 2014752705
Granted/Registered
European Patent
08.06.2016 A
27.02.2019 B1
01.08.2013
US
201361861198 P
08.11.2013
US
201361901732 P
30.01.2014
US
201461933632 P
A61K 39/395 20060101AFI20180712BHEP
Owner
Five Prime Therapeutics, Inc.111 Oyster Point Boulevard South San Francisco, CA 94080US
Representative
No representatives present
Inventor
HARDING, ThomasTwo Corporate Drive South San Francisco California 94080US
PIERCE, KristenTwo Corporate Drive South San Francisco California 94080US
PATIL, NamrataTwo Corporate Drive South San Francisco California 94080US
BRENNAN, ThomasTwo Corporate Drive South San Francisco California 94080US
HAMBLETON, JulieTwo Corporate Drive South San Francisco California 94080US
Information about Fees